MENU
JBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Jade Biosciences (JBIO) Ownership - Who owns Jade Biosciences?
Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
241.45M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
JBIO
Capitalization
241M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
75.8M
Shares Outstanding - Current
32.2M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
182.642
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. JBIO showed earnings on May 19, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information